NIH supports collaborative research on cardiovascular disease in type 1 diabetes through continuation of the Cardiovascular Repository for Type 1 Diabetes consortium; clinical trials are not allowed.
Funder: National Institutes of Health
Due Dates: October 9, 2026 (New) | November 9, 2026 (Renewal/resubmission/revision) | February 10, 2027 (New) | March 10, 2027 (Renewal/resubmission/revision)
Funding Amounts: Up to $500,000 in direct costs annually for up to three years, plus applicable F&A costs
Summary: Supports collaborative, hypothesis-driven research using CaRe-T1D human cardiovascular tissue to understand cardiovascular disease in type 1 diabetes.
Key Information: Projects must primarily use CaRe-T1D tissue resources; clinical trials and new human tissue or blood collection are not responsive.
This open competition continues the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) consortium through NIH U01 cooperative agreements, with participation from NIDDK and NHLBI. The program supports interdisciplinary research into the molecular and cellular mechanisms of cardiovascular disease in people with type 1 diabetes (T1D), including differences from type 2 diabetes. CaRe-T1D provides human cardiovascular tissues and associated data for discovery and mechanistic research.
Projects should test specific hypotheses using repository tissues as their primary experimental system. Relevant areas include atherosclerosis, myocardial remodeling and fibrosis, mitochondrial metabolism, immune dysregulation, small vessel disease, cardiac autonomic neuropathy, peripheral artery disease, biomarkers, and organ-on-a-chip models. The consortium emphasizes collaboration across investigative teams, integration of findings from shared donor tissues, and sharing of data, protocols, and research resources.